You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Policy & Regulation
New Preclinical Research Suggests Tetra Therapeutics' BPN14770 Protects Against Memory Loss and Neuronal Atrophy in Alzheimer's Disease
Login
Username:

Password:


Related Headlines

EU approves DAWNZERA for hereditary angioedema

Charles River collaborates with Gazi University on rare disease gene therapy research

Avacta secures FDA clearance for second pre|CISION oncology programme

LEO Pharma advances delgocitinib cream into phase 3 trial for lichen sclerosus

Syngene International and Bristol Myers Squibb extend collaboration to 2035

Rakuten Medical expands academic access to IR700 dye

Insilico Medicine signs co-development collaboration agreement with Hygtia Therapeutics

HistoIndex partners Houston Research Institute

GSK agrees to acquire RAPT Therapeutics to strengthen food allergy pipeline

Alcami acquires RTP facility in Durham, NC

Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis

EMA validates Daiichi Sankyo's ENHERTU plus pertuzumab application for first-line HER2 positive metastatic breast cancer

Immunovia gains California approval for PancreaSure and begins commercial rollout

Profusa launches Lumee tissue oxygen system for CRO market

Zylox-Tonbridge agrees staged acquisition of Germany's Optimed

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026